Fund shareholders of ARCADIA BIOSCIENCES INC
ISIN US0390143032 · United States · LEI 54930027ZPNA80B8O763
- Fund shareholders
- 4
- Of which ETFs
- 0 4 other funds
- Value held
- 36.7K $
- Share of capital
- 1.7 % of 2.4M shares on Aug 6, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 27,879 | 26.9K $ | 0.00 % | 1.16 % | as of May 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 9,644 | 6.5K $ | 0.40 % | as of Jun 30, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 1,716 | 1.7K $ | 0.07 % | as of May 31, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 1,626 | 1.6K $ | 0.07 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 4 | 0 | 40,865 | +105.6 % |
| 2026Q2 | 4 | 0 | 19,879 | 0.0 % |
| 2026Q1 | 4 | 0 | 19,879 | -0.2 % |
| 2025Q4 | 4 | 0 | 19,928 | -18.2 % |
| 2025Q3 | 4 | 0 | 24,371 | -0.6 % |
| 2025Q2 | 4 | 0 | 24,515 | +1.3 % |
| 2025Q1 | 4 | -1 | 24,197 | +8.8 % |
| 2024Q4 | 5 | 0 | 22,241 | +5.8 % |
| 2024Q3 | 5 | 0 | 21,030 | -0.3 % |
| 2024Q2 | 5 | 0 | 21,084 | 0.0 % |
| 2024Q1 | 5 | 0 | 21,084 | +52.6 % |
| 2023Q4 | 5 | 13,814 |
Institutional managers
13 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 159,390 | 220K $ | as of Mar 31, 2026 |
| SABBY MANAGEMENT, LLC | 114,554 | 158.1K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 31,743 | 43.8K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 12,614 | 17.4K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 12,146 | 16.8K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 3,940 | 5.4K $ | as of Mar 31, 2026 |
| UBS Group AG | 807 | 1.1K $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 120 | 166 $ | as of Mar 31, 2026 |
| GROUP ONE TRADING LLC | 18 | 25 $ | as of Mar 31, 2026 |
| ASSETMARK, INC | 5 | 7 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2 | 3 $ | as of Mar 31, 2026 |
| SOUTHERN MICHIGAN BANK & TRUST | 2 | 3 $ | as of Mar 31, 2026 |
| CITIGROUP INC | 1 | 1 $ | as of Mar 31, 2026 |
Declared shareholders of ARCADIA BIOSCIENCES INC
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| MJL Manager LLC and 2 others | 15.70 % | 378,740 | as of Sep 25, 2026 · SCHEDULE 13G |
| Armistice Capital, LLC and 1 other | 9.99 % | 267,392 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of ARCADIA BIOSCIENCES INC". https://titelia.com/en/stocks/arcadia-biosciences-inc-US0390143032